Stock Track | Sotera Health Plummets 5.06% in Pre-Market amid Mixed Q4 Results and Weak 2025 Outlook

Stock Track02-27

Sotera Health Company's (SHC) stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.

The company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year to $290.2 million, missing the analyst consensus of $290.88 million. Furthermore, Sotera Health's guidance for 2025 adjusted earnings per share of $0.70 to $0.76 fell short of analyst expectations of $0.78.

The disappointing revenue performance and weaker-than-expected outlook for 2025 appear to have dampened investor sentiment, leading to the significant pre-market sell-off in Sotera Health's shares. Despite the mixed results, analysts maintained an overall "buy" rating on the stock, indicating confidence in the company's long-term prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156555948?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 23:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156555948","market":"us","top_or_hot":-1,"title":"Stock Track | Sotera Health Plummets 5.06% in Pre-Market amid Mixed Q4 Results and Weak 2025 Outlook","media":"Stock Track","content":"<p>Sotera Health Company's (SHC) stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.</p>\n\n<p>The company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year to $290.2 million, missing the analyst consensus of $290.88 million. Furthermore, Sotera Health's guidance for 2025 adjusted earnings per share of $0.70 to $0.76 fell short of analyst expectations of $0.78.</p>\n\n<p>The disappointing revenue performance and weaker-than-expected outlook for 2025 appear to have dampened investor sentiment, leading to the significant pre-market sell-off in Sotera Health's shares. Despite the mixed results, analysts maintained an overall \"buy\" rating on the stock, indicating confidence in the company's long-term prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Sotera Health Plummets 5.06% in Pre-Market amid Mixed Q4 Results and Weak 2025 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Sotera Health Plummets 5.06% in Pre-Market amid Mixed Q4 Results and Weak 2025 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 23:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sotera Health Company's (SHC) stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.</p>\n\n<p>The company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year to $290.2 million, missing the analyst consensus of $290.88 million. Furthermore, Sotera Health's guidance for 2025 adjusted earnings per share of $0.70 to $0.76 fell short of analyst expectations of $0.78.</p>\n\n<p>The disappointing revenue performance and weaker-than-expected outlook for 2025 appear to have dampened investor sentiment, leading to the significant pre-market sell-off in Sotera Health's shares. Despite the mixed results, analysts maintained an overall \"buy\" rating on the stock, indicating confidence in the company's long-term prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SHC","symbol_name":"Sotera Health Company","start_time":0,"source_url":"","article_id":"1156555948","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156555948","pubTimestamp":1740669220,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Sotera Health Company's  stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.The company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SHC":"Sotera Health Company"},"translate_title":"由于第四季度业绩好坏参半和2025年前景疲软，Sotera Health盘前暴跌5.06%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHC":1},"content_text":"Sotera Health Company's (SHC) stock plummeted by 5.06% in pre-market trading on Thursday, following the release of its fourth-quarter 2024 financial results. The healthcare company reported mixed results for the quarter, with earnings per share beating analyst estimates by a narrow margin but revenue falling short of expectations.\nThe company reported adjusted earnings of $0.21 per share, surpassing the consensus estimate of $0.20 by 5%. However, revenue for the quarter declined by 6.5% year-over-year to $290.2 million, missing the analyst consensus of $290.88 million. Furthermore, Sotera Health's guidance for 2025 adjusted earnings per share of $0.70 to $0.76 fell short of analyst expectations of $0.78.\nThe disappointing revenue performance and weaker-than-expected outlook for 2025 appear to have dampened investor sentiment, leading to the significant pre-market sell-off in Sotera Health's shares. Despite the mixed results, analysts maintained an overall \"buy\" rating on the stock, indicating confidence in the company's long-term prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156555948","isCrawlerRequest":true}